Infectious Diseases News and Research

RSS

Researchers launch clinical trial to test the efficacy of antidepressant against COVID-19

An antidepressant medication is being tested as a potential treatment for COVID-19 after University of Virginia School of Medicine researchers determined it may prevent dangerous overreactions by the immune system.

13 May 2020

Quest and Ortho Clinical Diagnostics join forces to expand COVID-19 antibody testing

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today announced it is working with Quest Diagnostics, the world's leading provider of diagnostic information services, to expand COVID-19 antibody testing to more than 20 Quest laboratories across the U.S.

13 May 2020

Ortho’s COVID-19 total antibody test receives CE Mark

Ortho Clinical Diagnostics, a global leader of in vitro diagnostics with a rich history of bringing critical tests for infectious diseases to market, today announced its COVID-19 total antibody test received CE Mark.

From Ortho-Clinical Diagnostics, Inc. 13 May 2020

UCF researchers win $200,000 to develop cough drops for controlling COVID-19 spread

A team of University of Central Florida researchers is looking at changing people's saliva to help manage the spread of COVID-19 as the nation gets ready to go back to work and school.

12 May 2020

COVID-19 may contribute to exponential growth of Parkinson's disease in future

Parkinson's disease (PD) is expected to reach over 14 million cases worldwide by 2040. As longevity increases, so does the number of persons living with PD.

12 May 2020

Rotavirus vaccination leads to a decrease in hospitalizations and deaths of children

Vaccination against rotavirus has led to a significant decrease in hospitalisations and deaths of children due to severe diarrhoea in the Western Pacific region, a new study has found.

12 May 2020

Clinical trial to evaluate two-drug immunotherapy combination in cancer patients with COVID-19

A unique two-drug immunotherapy combination first evaluated at Roswell Park Comprehensive Cancer Center as an approach for treating some cancers will soon be available to cancer patients with COVID-19 through a clinical trial at Roswell Park.

12 May 2020

Novel telemedicine platform protects health professionals caring for patients with infectious diseases

Physician-scientists have developed a communication management system built on a telemedicine platform that can help minimize the exposure of health care professionals to highly infectious diseases while still providing personalized patient care, according to a new report published online in the Annals of the American Thoracic Society.

12 May 2020

Study sheds more light on the evolutionary ancestry of SARS-CoV-2

There is ongoing debate among policymakers and the general public about where SARS-CoV-2, the virus that causes COVID-19, came from. While researchers consider bats the most likely natural hosts for SARS-CoV-2, the origins of the virus are still unclear.

12 May 2020

Collaborative approach is essential to speed up COVID-19 vaccine candidates, say NIH experts

A harmonized and collaborative approach to the clinical testing, scale-up and distribution of candidate vaccines to prevent COVID-19 is essential, scientific leaders write in a perspective published today in Science.

12 May 2020

Genomic sequences from all over the world help fight SARS-CoV-2

As the COVID-19 pandemic rages across the world, killing hundreds of thousands and infecting over 4.1 million, researchers are racing against time to understand the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The SARS-CoV-2 genome has now been sequenced in many different regions of the world, and researchers are collaborating by sharing information to better understand the make-up and mutations that the virus has undergone.

11 May 2020

New diagnostic approach has potential to enhance infectious diseases surveillance

A new technique could provide vital information about a community's immunity to infectious diseases including malaria and COVID-19.

11 May 2020

Microbiome controls the fitness of our immune system

Working alongside colleagues in Mainz, Bern, Hannover and Bonn, researchers from Charité - Universitätsmedizin Berlin, the Berlin Institute of Health and the German Rheumatism Research Center Berlin were able to show how the microbiome helps to render the immune system capable of responding to pathogens.

11 May 2020

Regeneron and CCPM collaborate to advance human genetics, precision medicine

Regeneron Pharmaceuticals, Inc. and the Colorado Center for Personalized Medicine at the University of Colorado Anschutz Medical Campus today announced a large-scale research collaboration designed to advance the field of human genetics and precision medicine through the sharing of 450,000 DNA samples and corresponding health records from de-identified, consented patient participants in the expansive UCHealth system.

11 May 2020

Novel approach could lead to more targeted search for new medicinal plants

With their rich repertoire of anti-infective substances, medicinal plants have always been key in the human fight to survive pathogens and parasites.

11 May 2020

Fred Hutch, NIH experts outline an efficient approach to creating COVID-19 vaccines

Unprecedented collaboration and resources will be required to research and develop safe and effective vaccines for COVID-19 that can be manufactured and delivered in the scale of billions of doses to people globally.

11 May 2020

Southwest CEO’s boast about airplanes’ low COVID risk flies by key concerns

During a May 3 appearance on "Face the Nation," Southwest CEO Gary Kelly said that he believed it was safe for Americans to fly during the coronavirus epidemic and that a plane is as safe as any other space.

11 May 2020

Analysis: We knew the coronavirus was coming, yet we failed 5 critical tests

The arrival of COVID-19 has provided a nuclear-level stress test to the American health care system, and our grade isn't pretty: at least 73,000 dead, 1.2 million infected and 30 million unemployed; nursing homes, prisons and meatpacking plants that have become hotbeds of infection.

11 May 2020

Italy develops vaccine candidate that neutralizes SARS-CoV-2 in mice

As the world grapples with the coronavirus disease (COVID-19), scientists race to develop treatments and vaccines to combat the viral infection. Though many ongoing trials show promise in fighting the novel coronavirus, Italian researchers claim they have developed a vaccine that can neutralize severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in animal cells.

10 May 2020

NIH clinical trial evaluates antiviral plus anti-inflammatory drug for COVID-19

A randomized, controlled clinical trial evaluating the safety and efficacy of a treatment regimen of the investigational antiviral remdesivir plus the anti-inflammatory drug baricitinib for coronavirus disease 2019 (COVID-19) has begun.

8 May 2020

Infectious Diseases News and Research

Researchers launch clinical trial to test the efficacy of antidepressant against COVID-19

Quest and Ortho Clinical Diagnostics join forces to expand COVID-19 antibody testing

Ortho’s COVID-19 total antibody test receives CE Mark

UCF researchers win $200,000 to develop cough drops for controlling COVID-19 spread

COVID-19 may contribute to exponential growth of Parkinson's disease in future

Rotavirus vaccination leads to a decrease in hospitalizations and deaths of children

Clinical trial to evaluate two-drug immunotherapy combination in cancer patients with COVID-19

Novel telemedicine platform protects health professionals caring for patients with infectious diseases

Study sheds more light on the evolutionary ancestry of SARS-CoV-2

Collaborative approach is essential to speed up COVID-19 vaccine candidates, say NIH experts

Genomic sequences from all over the world help fight SARS-CoV-2

New diagnostic approach has potential to enhance infectious diseases surveillance

Microbiome controls the fitness of our immune system

Regeneron and CCPM collaborate to advance human genetics, precision medicine

Novel approach could lead to more targeted search for new medicinal plants

Fred Hutch, NIH experts outline an efficient approach to creating COVID-19 vaccines

Southwest CEO’s boast about airplanes’ low COVID risk flies by key concerns

Analysis: We knew the coronavirus was coming, yet we failed 5 critical tests

Italy develops vaccine candidate that neutralizes SARS-CoV-2 in mice

NIH clinical trial evaluates antiviral plus anti-inflammatory drug for COVID-19

Industry Focus eBook - Infectious Diseases (3rd Edition) eBook

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News